Auris, nasus, larynx · 2026
Current status of powered intracapsular tonsillectomy and adenoidectomy: A minimally invasive paradigm for pediatric obstructive sleep apnea surgery.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kono Masamitsu, Noda Masao, Komori Manabu, Yokoyama Nayu, Hamamoto Masakazu, Shimada Mari, Hara Hirotaka, Ito Makoto
Аннотация
OBJECTIVE: To provide a practical, evidence-informed guide for clinicians on powered intracapsular tonsillectomy and adenoidectomy (PITA) in pediatric patients.
METHODS: A narrative synthesis of contemporary studies, metaanalyses, and guideline statements on indications, techniques, devices, outcomes, complications, and implementation considerations for PITA was conducted. Device parameters and workflow tips are provided for practical reference.
RESULTS: PITA consistently reduces secondary hemorrhage and pain, shortens the time to resumption of normal diet and activity and lowers the risk of readmission for dehydration relative to conventional extracapsular tonsillectomy. It also results in comparable resolution of obstructive symptoms in appropriately selected children. Endoscopic powered adenoidectomy enables complete, targeted resection under direct vision, protects the Eustachian tube and soft palate, and reduces revision rates relative to blind curettage. The trade-offs include a small but real risk of tonsillar regrowth (⁓2-6%) and a learning curve for powered/endoscopic techniques. The practical device settings (coblation ablation, 7-9; microdebrider, 600-800 rpm), endoscopic routes (transoral, 70°; transnasal, 0°), and safety pearls are provided.
CONCLUSIONS: PITA is a safe, efficient, and patient-centered treatment option for pediatric adenotonsillar disease, especially obstructive sleep apnea, when performed with endoscopic visualization and capsule preservation. Standardization of training, perioperative management including postoperative pain control and recovery course, and long-term outcome tracking will further promote its adoption in guidelines.
METHODS: A narrative synthesis of contemporary studies, metaanalyses, and guideline statements on indications, techniques, devices, outcomes, complications, and implementation considerations for PITA was conducted. Device parameters and workflow tips are provided for practical reference.
RESULTS: PITA consistently reduces secondary hemorrhage and pain, shortens the time to resumption of normal diet and activity and lowers the risk of readmission for dehydration relative to conventional extracapsular tonsillectomy. It also results in comparable resolution of obstructive symptoms in appropriately selected children. Endoscopic powered adenoidectomy enables complete, targeted resection under direct vision, protects the Eustachian tube and soft palate, and reduces revision rates relative to blind curettage. The trade-offs include a small but real risk of tonsillar regrowth (⁓2-6%) and a learning curve for powered/endoscopic techniques. The practical device settings (coblation ablation, 7-9; microdebrider, 600-800 rpm), endoscopic routes (transoral, 70°; transnasal, 0°), and safety pearls are provided.
CONCLUSIONS: PITA is a safe, efficient, and patient-centered treatment option for pediatric adenotonsillar disease, especially obstructive sleep apnea, when performed with endoscopic visualization and capsule preservation. Standardization of training, perioperative management including postoperative pain control and recovery course, and long-term outcome tracking will further promote its adoption in guidelines.